Mario Castro MD MPH

Pulmonology•Kansas City, KS

Asthma & COPD, Critical Care Medicine, Interventional Pulmonology, Pleural Disease

Professor, Chief, Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine

Join to View Full Profile

4000 Cambridge StMSN 3007Kansas City, KS 66160
Phone+1 913-588-7529
Fax+1 913-535-2200

Summary

Dr. Mario Castro is a pulmonologist in Kansas City, KS and is affiliated with The University of Kansas Health System. He received his medical degree from University of Missouri - Kansas City School of Medicine and has been in practice 29 years. He specializes in asthma & copd, critical care medicine, interventional pulmonology, and pleural disease and is experienced in asthma, chronic obstructive pulmonary disease, lymphangioleiomyomatosis, sarcoidosis, and airway remodeling.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1994
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1988 - 1991
University of Missouri Kansas City School of MedicineClass of 1988

Certifications & Licensure

MO State Medical License 1994 - 2026
KS State Medical License 2019 - 2025
FL State Medical License 1990 - 1994
IA State Medical License 1991 - 1994
MN State Medical License 1989 - 1994
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE) Start of enrollment: 2004 Dec 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA) Start of enrollment: 2006 Jun 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT) Start of enrollment: 2007 Jun 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC) Start of enrollment: 2008 May 01
Completed
Phase 3
Long-term Oxygen Treatment Trial Start of enrollment: 2009 Jan 01
Completed
Phase 3
Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA) Start of enrollment: 2010 Nov 01
Completed
Phase 2
A Prospective Observational Study of Biopredictors of Bronchial Thermoplasty Response in Patients With Severe Refractory Asthma (BTR Study) Start of enrollment: 2010 Aug 01
Completed
Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma Start of enrollment: 2011 Apr 01
Completed
Phase 3
Long-acting Beta Agonist Step Down Study Start of enrollment: 2012 Mar 01
Completed
Phase 4
Severe Asthma Research Program
ACTIVE_NOT_RECRUITING
Washington University Severe Asthma Research Program III Start of enrollment: 2012 Oct 01
Active, not recruiting
Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma Start of enrollment: 2013 Mar 01
Unknown status
Phase 2
Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction Start of enrollment: 2014 Mar 01
Completed
Phase 2
Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI Start of enrollment: 2013 Mar 01
Completed
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

Design and Implementation of a Multi-Center Trial ofXe Gas Exchange MRI and MRS to Evaluate Longitudinal Progression of COPD.
Bastiaan Driehuys, Shuo Zhang, Aryil Bechtel, Andrew D Hahn, Guilhem Collier
Journal of Magnetic Resonance Imaging. 2025-04-23
Efficacy of Biologics in Reducing Exacerbations Requiring Hospitalization or an Emergency Department Visit in Patients with Moderate or Severe, Uncontrolled Asthma.
Reynold A Panettieri Jr, Monica Kraft, Mario Castro, Magdalena Bober, Andrew W Lindsley
Advances in Therapy. 2025-04-22
1 citations
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials.
Fleur L Meulmeester, Samuel Mailhot-Larouche, Carlos Celis-Preciado, Samuel Lemaire-Paquette, Sanjay Ramakrishnan
The Lancet. Respiratory Medicine. 2025-04-08

Press Mentions

Dupilumab Boosts Lung Function in Patients with Type 2 AsthmaMarch 18th, 2025
Ivermectin Shown Ineffective in Treating COVID-19, According to Multi-Site Study Including KU Medical CenterDecember 1st, 2022
American College of Chest Physicians, Oct. 16-19October 31st, 2022
Join now to see all